Table 2.
Weighted prevalences in breast cancer, prostate cancer, and multiple myeloma patients.
| Breast Cancer | Prostate Cancer | Multiple Myeloma | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Cases | prev | n | Cases | prev | n | Cases | prev | n | Cases | prev | |
| −2009 | 5531 | 156 | 2.82% | 732 | 44 | 6.01% | 6796 | 344 | 5.06% | 13,059 | 544 | 4.17% |
| 2010+ | 11,101 | 192 | 1.73% | 3504 | 117 | 3.34% | 1773 | 98 | 5.53% | 16,378 | 407 | 2.49% |
| Total | 16,632 | 348 | 2.09% | 4236 | 161 | 3.80% | 8569 | 442 | 5.16% | 29,437 | 951 | 3.23% |
Abbreviations: n (number of patients); prev (prevalence); Cases (number of patients with ONJ).